SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $70,056,000 | -10.5% | 400,000 | 0.0% | 2.25% | -16.7% |
| Q3 2020 | $78,276,000 | +15.2% | 400,000 | 0.0% | 2.70% | -9.5% |
| Q2 2020 | $67,968,000 | +47.3% | 400,000 | 0.0% | 2.99% | -5.0% |
| Q1 2020 | $46,152,000 | -19.2% | 400,000 | -20.0% | 3.15% | -2.6% |
| Q4 2019 | $57,130,000 | +783.3% | 500,000 | +300.0% | 3.23% | +110.1% |
| Q2 2017 | $6,468,000 | +2.9% | 125,000 | +25.0% | 1.54% | +11.9% |
| Q1 2017 | $6,286,000 | +19.1% | 100,000 | 0.0% | 1.37% | -32.7% |
| Q4 2016 | $5,277,000 | -58.0% | 100,000 | -57.0% | 2.04% | -63.8% |
| Q3 2016 | $12,563,000 | +33.7% | 232,600 | 0.0% | 5.63% | -32.4% |
| Q2 2016 | $9,399,000 | +14.7% | 232,600 | -0.4% | 8.33% | +3.9% |
| Q1 2016 | $8,197,000 | +14.1% | 233,600 | +46.0% | 8.02% | +29.4% |
| Q4 2015 | $7,181,000 | – | 160,000 | – | 6.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |